BMY Bristol Myers Squibb Co

Price (delayed)

$64.83

Market cap

$146.5B

P/E Ratio

N/A

Dividend/share

$1.84

EPS

-$0.28

Enterprise value

$172.01B

Sector: Healthcare
Industry: Drug Manufacturers - General

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights

Bristol Myers Squibb's equity has soared by 184% YoY and by 2.2% from the previous quarter
Bristol Myers Squibb's gross profit has soared by 66% YoY and by 16% from the previous quarter
The net income has dropped by 101% year-on-year but it has surged by 92% since the previous quarter
BMY's debt has soared by 80% year-on-year but it is down by 3.7% since the previous quarter
Bristol Myers Squibb's EPS has shrunk by 108% YoY

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.26B
Market cap
$146.5B
Enterprise value
$172.01B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.91
Price to sales (P/S)
3.71
EV/EBIT
50.08
EV/EBITDA
13.92
EV/Sales
4.37
Earnings
Revenue
$39.4B
EBIT
$3.44B
EBITDA
$12.36B
Free cash flow
$11.7B
Per share
EPS
-$0.28
Free cash flow per share
$5.19
Book value per share
$22.25
Revenue per share
$17.48
TBVPS
$21.44
Balance sheet
Total assets
$125.54B
Total liabilities
$75.31B
Debt
$44.95B
Equity
$50.16B
Working capital
$13.81B
Liquidity
Debt to equity
0.9
Current ratio
1.67
Quick ratio
1.43
Net debt/EBITDA
2.06
Margins
EBITDA margin
31.4%
Gross margin
71.3%
Net margin
-0.1%
Operating margin
8.8%
Efficiency
Return on assets
0%
Return on equity
-0.1%
Return on invested capital
6.2%
Return on capital employed
3.3%
Return on sales
8.7%
Dividend
Dividend yield
2.84%
DPS
$1.84
Payout ratio
N/A

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
0.42%
1 week
-2.57%
1 month
6.02%
1 year
1.04%
YTD
4.51%
QTD
4.51%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$39.4B
Gross profit
$28.1B
Operating income
$3.45B
Net income
-$44M
Gross margin
71.3%
Net margin
-0.1%
The net income has dropped by 101% year-on-year but it has surged by 92% since the previous quarter
BMY's net margin has dropped by 100% year-on-year but it has soared by 94% since the previous quarter
The operating margin has dropped by 68% year-on-year but it has increased by 21% since the previous quarter
Bristol Myers Squibb's gross profit has soared by 66% YoY and by 16% from the previous quarter

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
N/A
P/B
2.91
P/S
3.71
EV/EBIT
50.08
EV/EBITDA
13.92
EV/Sales
4.37
Bristol Myers Squibb's EPS has shrunk by 108% YoY
Bristol Myers Squibb's equity has soared by 184% YoY and by 2.2% from the previous quarter
BMY's P/B is 49% below its 5-year quarterly average of 5.7 but 16% above its last 4 quarters average of 2.5
The company's revenue has surged by 63% YoY and by 13% QoQ
The price to sales (P/S) is 18% less than the 5-year quarterly average of 4.5 and 2.4% less than the last 4 quarters average of 3.8

Efficiency

How efficient is Bristol Myers Squibb business performance
The ROE has plunged by 100% YoY but it has soared by 92% from the previous quarter
Bristol Myers Squibb's ROA has soared by 100% from the previous quarter but it has plunged by 100% YoY
BMY's return on invested capital has dropped by 76% year-on-year but it is up by 24% since the previous quarter
Bristol Myers Squibb's return on sales has shrunk by 68% YoY but it has increased by 21% QoQ

Dividends

What is BMY's dividend history
DPS
$1.84
Dividend yield
2.84%
Payout ratio
N/A
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 67% greater than its total liabilities
The total liabilities has surged by 90% year-on-year but it has declined by 4.6% since the previous quarter
The quick ratio has shrunk by 61% YoY but it has increased by 13% QoQ
BMY's debt is 10% smaller than its equity
Bristol Myers Squibb's equity has soared by 184% YoY and by 2.2% from the previous quarter
BMY's debt has soared by 80% year-on-year but it is down by 3.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.